Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

How to launch a drug in a pandemic with Immunomedics

Immunomedics’ first approved is Trodelvy, an ADC indicated for heavily treated metastatic TNBC. Credit: Shutterstock.



  • launch a drug in a pandemic Immunomedics
Close
Close
Close

Go Top